Pharmabiz

IIT Madras launches finishing school to develop industry-ready biotechnology professionals

IIT Madras launches finishing school to develop industry-ready biotechnology professionals: Our Bureau, Mumbai Wednesday, October 21, 2026, 17:40 Hrs [IST] Indian Institute of Tec ...
PharmabizOpinion

BDCDA asserts its 2023 Rituximab test purchase exposed big discrepancies between printed MRPs & actual billing prices

BDCDA asserts its 2023 Rituximab test purchase exposed big discrepancies between printed MRPs & actual billing prices: ...
Pharmabiz

Terna Speciality Hospital hosts TPA & Insurance Scientific Conclave 2026 towards transparent, patient-centric healthcare financing

Terna Speciality Hospital hosts TPA & Insurance Scientific Conclave 2026 towards transparent, patient-centric healthcare ...
Pharmabiz

RDCA Delhi welcomes government move to rationalize trade margins on anti-cancer drugs

RDCA Delhi welcomes government move to rationalize trade margins on anti-cancer drugs: Peethaambaran Kunnathoor, Chennai ...
Pharmabiz

Bharat Biotech’s Nucelion & VeGen Bio to build end-to-end pathway for cell therapy innovation

Bharat Biotech’s Nucelion & VeGen Bio to build end-to-end pathway for cell therapy innovation: Our Bureau, Bengaluru Wednesday, October 21, 2026, 16:10 Hrs [IST] Nucelion Therap ...
Pharmabiz

Clene seeks US FDA approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis

Clene seeks US FDA approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis: Salt Lake City Wednesday, October 21, 2026, 17:00 Hrs [IST] Clene Inc., a clinical-stag ...
Pharmabiz

Insmed introduces Brinsupri tablets 25 mg to treat non-cystic fibrosis bronchiectasis in Japan

Insmed introduces Brinsupri tablets 25 mg to treat non-cystic fibrosis bronchiectasis in Japan: Bridgewater, New Jersey Wednesday, October 21, 2026, 16:00 Hrs [IST] Insmed Incorpo ...
Pharmabiz

Motorica launches local production of its own bionic prostheses in India

Motorica launches local production of its own bionic prostheses in India: Our Bureau, Bengaluru Wednesday, October 21, 2026, 15:50 Hrs [IST] Motorica Group, a leading Russian MedT ...
Pharmabiz

Sanofi gets CDSCO approval for Qfitlia in India

The Central Drugs Standard Control Organization (CDSCO), under the Drug Controller General of India (DCGI), has granted Marketing Authorization to Qfitlia (Fitusiran), the first antithrombin-lowering ...
Pharmabiz

Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio

Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio: Basel Wednesday, October 21, 2026, 15:00 Hrs [IST] Roche wi ...
Pharmabiz

Enable Injections announces approval in Japan for CirCLIQ Injector based on enFuse On-Body Delivery System

Enable Injections announces approval in Japan for CirCLIQ Injector based on enFuse On-Body Delivery System: Cincinnati Wednesday, October 21, 2026, 14:00 Hrs [IST] Enable Injectio ...
Pharmabiz

Dr. Reddy’s receives DCGI Approval for Zytorvi

Dr. Reddy’s Laboratories Ltd. announced that the Central Drugs Standard Control Organisation (CDSCO), under the Drugs Controller General of India (DCGI), has approved Zytorvi (toripalimab) in ...